TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

15.40$ -8.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Cullinan Oncology LLC (CGEM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 364 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGEM
Line item Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 – – – 100 – 105 222 215 480 464 453 437 437 667 617 561 515 522 495 484 449 681 653 622 580 520 484 448 403 364
– – – – 0.0 0.0 0.1 0.0 0.0 0.0 34 – – 100 99 105 222 212 447 344 329 297 322 623 582 474 399 498 477 480 446 678 592 415 318 276 342 387 361 342
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -34 – – 63 -99 51 166 168 294 124 88 60 76 354 243 156 122 142 65 98 74 115 102 83 77 73 103 88 75 79
– – – – – – – – – – 34 – – 99 99 103 220 210 441 337 321 290 315 611 576 467 391 492 466 467 433 662 578 399 304 265 333 378 352 335
– – – – 0.0 – 0.0 – 0.0 0.0 – – – – – – – – – – – – – – – – – – – 5.4 – – – 3.0 – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – -5.4 – – – – – – – – – –
– – – – – – – – – – – – – – 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 5.3 1.2 1.2 1.2 – – – – – – – – – – – –
0.9 0.9 0.9 0.9 0.8 0.9 1.5 0.5 0.5 0.6 – – – 140 – 6.0 7.8 14 10.0 5.8 7.9 12 18 63 31 26 29 22 26 30 24 25 25 31 28 28 33 40 37 42
0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.2 0.2 0.2 – – – 2.5 6.0 6.0 7.7 14 9.9 5.7 7.9 12 17 62 27 22 26 20 23 28 22 23 24 31 27 28 33 38 35 41
– – – – 1.1 1.1 – – 0.3 0.3 – – – – – – – – – – – – 1.3 0.5 0.7 1.6 3.4 3.5 3.5 1.4 1.3 1.2 1.3 1.3 1.3 1.4 1.2 0.8 0.7 0.7
0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 – – – 0.9 4.5 4.5 3.5 9.7 3.9 1.5 2.0 3.2 6.3 3.1 1.5 2.7 2.0 2.5 1.0 2.5 3.7 1.6 2.1 1.7 3.4 2.5 1.7 0.8 2.5 3.7
– – – – 1.1 1.1 0.4 0.3 0.3 0.3 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – -1.2 -1.2 -1.3 -0.5 -0.5 -0.6 33 – – -41 98 98 212 199 467 456 443 425 419 605 586 535 486 500 469 454 426 656 628 590 552 492 451 409 366 322
– – – – -2.8 -2.8 -2.9 -3.1 -3.1 -3.2 – – – -42 -55 -55 -65 -93 -93 -109 -126 -159 -171 3.9 -21 -48 -106 -138 -177 -201 -238 -280 -321 -368 -417 -487 -537 -588 -638 -691
– – – – – – – – – – 0.8 0.8 1.0 1.1 19 19 38 42 42 43 43 44 44 46 46 46 41 40 43 43 43 55 58 59 59 59 59 59 59 61

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?